These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32068430)

  • 1. Characteristics and circumstances of death related to gamma hydroxybutyrate (GHB).
    Darke S; Peacock A; Duflou J; Farrell M; Lappin J
    Clin Toxicol (Phila); 2020 Nov; 58(11):1028-1033. PubMed ID: 32068430
    [No Abstract]   [Full Text] [Related]  

  • 2. Characteristics and circumstances of death related to the self-administration of ketamine.
    Darke S; Duflou J; Farrell M; Peacock A; Lappin J
    Addiction; 2021 Feb; 116(2):339-345. PubMed ID: 32533718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity.
    Liakoni E; Walther F; Nickel CH; Liechti ME
    Scand J Trauma Resusc Emerg Med; 2016 Aug; 24(1):107. PubMed ID: 27581664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case series of 226 γ-hydroxybutyrate-associated deaths: lethal toxicity and trauma.
    Zvosec DL; Smith SW; Porrata T; Strobl AQ; Dyer JE
    Am J Emerg Med; 2011 Mar; 29(3):319-32. PubMed ID: 20825811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous concentrations of GHB in postmortem blood from deaths unrelated to GHB use.
    Korb AS; Cooper G
    J Anal Toxicol; 2014 Oct; 38(8):582-8. PubMed ID: 25217550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and circumstances of death related to new psychoactive stimulants and hallucinogens in Australia.
    Darke S; Duflou J; Peacock A; Farrell M; Lappin J
    Drug Alcohol Depend; 2019 Nov; 204():107556. PubMed ID: 31546120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicentre case series of analytically confirmed gamma-hydroxybutyrate intoxications in Western Australian emergency departments: Pre-hospital circumstances, co-detections and clinical outcomes.
    Smith JL; Greene S; McCutcheon D; Weber C; Kotkis E; Soderstrom J; Douglas B; Lenton S; Grigg J; Dessauer P; Ezard N; Fatovich DM;
    Drug Alcohol Rev; 2024 May; 43(4):984-996. PubMed ID: 38426636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forensic toxicology findings in deaths involving gamma-hydroxybutyrate.
    Kugelberg FC; Holmgren A; Eklund A; Jones AW
    Int J Legal Med; 2010 Jan; 124(1):1-6. PubMed ID: 19048269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpreting γ-hydroxybutyrate concentrations for clinical and forensic purposes.
    Busardò FP; Jones AW
    Clin Toxicol (Phila); 2019 Mar; 57(3):149-163. PubMed ID: 30307336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics, toxicology and major organ pathology of deaths due to acute alcohol toxicity in Australia, 2011-2022.
    Darke S; Duflou J; Peacock A; Chrzanowska A; Yuen WS; Farrell M; Lappin J
    Drug Alcohol Rev; 2024 May; 43(4):937-945. PubMed ID: 38345860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A descriptive coronial study of heroin toxicity deaths in Australia, 2020-2022: Characteristics, toxicology and survival times.
    Darke S; Duflou J; Peacock A; Farrell M; Lappin J
    Addiction; 2024 Mar; 119(3):559-569. PubMed ID: 37921084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and circumstances of synthetic cannabinoid-related death.
    Darke S; Duflou J; Farrell M; Peacock A; Lappin J
    Clin Toxicol (Phila); 2020 May; 58(5):368-374. PubMed ID: 31389266
    [No Abstract]   [Full Text] [Related]  

  • 13. Deaths in the Lesbian, Gay, Bisexual and Transgender United Kingdom Communities Associated with GHB and Precursors.
    Corkery JM; Loi B; Claridge H; Goodair C; Schifano F
    Curr Drug Metab; 2018; 19(13):1086-1099. PubMed ID: 29119924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.
    Busardò FP; Jones AW
    Curr Neuropharmacol; 2015 Jan; 13(1):47-70. PubMed ID: 26074743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-hydroxybutyrate concentrations in the blood of impaired drivers, users of illicit drugs, and medical examiner cases.
    Jones AW; Holmgren A; Kugelberg FC
    J Anal Toxicol; 2007; 31(9):566-72. PubMed ID: 18093415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and circumstances of death related to buprenorphine toxicity in Australia.
    Darke S; Duflou J; Larance B; Farrell M; Lappin J
    Drug Alcohol Depend; 2021 Jan; 218():108360. PubMed ID: 33268226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-hydroxybutyrate in urine and serum: additional data supporting current cut-off recommendations.
    Andresen H; Sprys N; Schmoldt A; Mueller A; Iwersen-Bergmann S
    Forensic Sci Int; 2010 Jul; 200(1-3):93-9. PubMed ID: 20418032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of GHB in tissues and fluids following a fatal overdose.
    Mazarr-Proo S; Kerrigan S
    J Anal Toxicol; 2005; 29(5):398-400. PubMed ID: 16105269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates, characteristics and circumstances of methamphetamine-related death in Australia: a national 7-year study.
    Darke S; Kaye S; Duflou J
    Addiction; 2017 Dec; 112(12):2191-2201. PubMed ID: 28603836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).
    Wood DM; Warren-Gash C; Ashraf T; Greene SL; Shather Z; Trivedy C; Clarke S; Ramsey J; Holt DW; Dargan PI
    QJM; 2008 Jan; 101(1):23-9. PubMed ID: 18203723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.